Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TV-1106 in Adults With Growth Hormone Deficiency
NCT01811576Phase 2Completed
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Mar 2013
- Primary completion
- Aug 2013
- Modality
- Fc-Fusion Proteins
- Countries
- 9
01
Overview
A Phase 2 trial of albusomatropin in growth hormone deficiency (GHD), sponsored by Teva Pharmaceutical Industries Ltd.. Started Mar 2013; status: completed.
02
Drugs
albusomatropin
03
Conditions
growth hormone deficiency (GHD)
Beyond the preview
Go deeper on NCT01811576.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01811576.